APA (7th ed.) Citation

L, S., V, N., E, D., S, L., F, B., R, I., . . . F, P. (2025). MSI-H locally recurrent rectal cancer: Immune checkpoint inhibitors vs. standard chemotherapy and pelvic exenteration. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 57(10), 2006. https://doi.org/10.1016/j.dld.2025.08.001

Chicago Style (17th ed.) Citation

L, Sorrentino, Nasca V, Daveri E, Lonardi S, Bergamo F, Intini R, Scardino A, Montroni I, and Pietrantonio F. "MSI-H Locally Recurrent Rectal Cancer: Immune Checkpoint Inhibitors Vs. Standard Chemotherapy and Pelvic Exenteration." Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 57, no. 10 (2025): 2006. https://doi.org/10.1016/j.dld.2025.08.001.

MLA (9th ed.) Citation

L, Sorrentino, et al. "MSI-H Locally Recurrent Rectal Cancer: Immune Checkpoint Inhibitors Vs. Standard Chemotherapy and Pelvic Exenteration." Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, vol. 57, no. 10, 2025, p. 2006, https://doi.org/10.1016/j.dld.2025.08.001.